DM109CZ
Brachytherapy Breast, Left to None with Californium 252 (Cf-252), High Dose Rate (HDR) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | M Breast |
| Operation | 1 Brachytherapy |
| Body Part | 0 Breast, Left |
| Approach | 9 High Dose Rate (HDR) |
| Device | C Californium 252 (Cf-252) |
| Qualifier | Z None |
Procedure Overview
Brachytherapy to the breast places a radioactive source directly inside breast tissue, usually within or near the cavity left after a lumpectomy, so that radiation is delivered from within the tissue rather than through the skin from an external machine. This approach, sometimes called accelerated partial breast irradiation, is offered to selected patients with early-stage breast cancer as an alternative to several weeks of external beam treatment, allowing the therapeutic course to be completed in a much shorter period, often about a week.
The source may be delivered through a balloon catheter or a set of thin tubes placed in the breast during a brief procedure, with the radioactive material inserted for short sessions and then withdrawn, or in some techniques left in place temporarily. Because the radiation is concentrated near the original tumor site, it can spare more of the surrounding healthy breast tissue and skin compared with treating the whole breast from outside.
Anatomy & Axis Detail
Breast, Left
Brachytherapy of the left breast involves placing a radioactive source directly within or adjacent to the tissue, most often into the lumpectomy cavity using a balloon or multi-catheter applicator, delivering a concentrated dose to the region at highest risk of recurrence while sparing more distant tissue. This localized approach is often selected for accelerated partial breast irradiation delivered over a shorter course than external beam treatment. Because the left breast lies near the heart, applicator placement and source dwell positions are planned to minimize any dose reaching deeper chest structures, and the compact glandular anatomy of the breast makes precise catheter or balloon geometry an important part of the procedure.
Modality Qualifier: High Dose Rate (HDR)
High Dose Rate (HDR) identifies brachytherapy delivered with a radioactive source of high activity, allowing treatment to be completed in minutes per fraction, often on an outpatient basis with afterloading applicators. It contrasts with Low Dose Rate (LDR), which uses a weaker source left in place for hours to days, trading a longer treatment time for a different radiobiological effect and staffing exposure profile.
Isotope: Californium 252 (Cf-252)
Californium-252 is a neutron-emitting source rather than a gamma or beta emitter, used in specialized brachytherapy for radioresistant tumors such as certain cervical or head and neck cancers where neutrons' higher relative biological effectiveness offers an advantage. It is far less commonly used than the gamma-emitting seed isotopes and is documented separately because its neutron output changes tissue interaction and shielding requirements.
Coding & Documentation
Coding from this family requires documentation confirming that a radioactive source was physically placed within or immediately adjacent to breast tissue, along with the device or technique used, such as a balloon applicator or interstitial catheters. The procedure note should specify whether the source was left in place temporarily for repeated treatments or delivered in a single session, since this affects whether multiple encounters need to be coded. A frequent mistake is coding the balloon or catheter placement procedure itself as brachytherapy when the radioactive source has not yet been loaded and delivered, when in fact insertion of the device and the radiation delivery may be reportable as distinct steps depending on timing. Coders should also confirm laterality and avoid defaulting to beam radiation coding simply because the case originated from the same radiation oncology course of care.
Commonly Confused With
The clearest distinction is from D|M|0 (Beam Radiation to the breast), separated by whether the radioactive source is placed inside the tissue versus aimed at it from an external device. It can also be confused with the surgical placement of the brachytherapy catheter or balloon itself, which may be coded separately from the radiation delivery depending on facility and payer conventions, so the record needs to clearly separate the insertion procedure from the radiation treatment sessions that follow it.